Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Flebogamma(®) DIF (intravenous immunoglobulin) purification process effectively eliminates procoagulant activities.

José M, Marzo N, Pons B, Herrerias A, López L, Faro M, López M, Jorquera JI.

Biologicals. 2013 Nov;41(6):393-9. doi: 10.1016/j.biologicals.2013.08.002. Epub 2013 Sep 17.

PMID:
24051302
[PubMed - in process]
2.

Assessment of the ability of the Privigen® purification process to deplete thrombogenic factor XIa from plasma.

Komenda M, Stadler D, Malinas T, Moses M, Pragst I, Herzog E, Schmutz P, Minnig K, El Menyawi I.

Vox Sang. 2014 Jul;107(1):26-36. doi: 10.1111/vox.12119. Epub 2013 Dec 13.

PMID:
24329163
[PubMed - in process]
3.

In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies.

Ma L, Sun P, Lin F, Diao G, Li C.

Thromb Res. 2013 Sep;132(3):381-5. doi: 10.1016/j.thromres.2013.07.020. Epub 2013 Jul 31.

PMID:
23953595
[PubMed - indexed for MEDLINE]
4.

Quantitative determination of activated coagulation factor XI as an impurity in therapeutic immunoglobulins from Chinese blood fractionation companies.

Ma L, Sun P, Lin FZ, Diao G, Li CQ.

Genet Mol Res. 2013 Jul 24;12(3):2556-61. doi: 10.4238/2013.January.4.17.

PMID:
23315876
[PubMed - indexed for MEDLINE]
Free Article
5.

Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products.

Etscheid M, Breitner-Ruddock S, Gross S, Hunfeld A, Seitz R, Dodt J.

Vox Sang. 2012 Jan;102(1):40-6. doi: 10.1111/j.1423-0410.2011.01502.x. Epub 2011 May 5.

PMID:
21545600
[PubMed - indexed for MEDLINE]
6.

Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations.

Wolberg AS, Kon RH, Monroe DM, Hoffman M.

Am J Hematol. 2000 Sep;65(1):30-4.

PMID:
10936860
[PubMed - indexed for MEDLINE]
7.

Assessment of immunoglobulin concentrates on thrombogenic activity by thrombin generation assay, prekallikrein activator assay, and size-exclusion chromatography.

Seifner A, Beck G, Bayer P, Eichmeir S, Lackner F, Rögelsperger O, Weber K, Wollein G.

Transfusion. 2014 Feb;54(2):376-83. doi: 10.1111/trf.12280. Epub 2013 Jun 17.

PMID:
23772713
[PubMed - indexed for MEDLINE]
8.

Clinical experience with Flebogamma 5% DIF: a new generation of intravenous immunoglobulins in patients with primary immunodeficiency disease.

Ballow M.

Clin Exp Immunol. 2009 Sep;157 Suppl 1:22-5. doi: 10.1111/j.1365-2249.2009.03951.x. Erratum in: Clin Exp Immunol. 2009 Sep;157(3):446.

PMID:
19630866
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Viral safety characteristics of Flebogamma DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin.

Caballero S, Nieto S, Gajardo R, Jorquera JI.

Biologicals. 2010 Jul;38(4):486-93. doi: 10.1016/j.biologicals.2010.02.008. Epub 2010 Mar 29.

PMID:
20350815
[PubMed - indexed for MEDLINE]
10.

Flebogamma 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy.

Jorquera JI.

Clin Exp Immunol. 2009 Sep;157 Suppl 1:17-21. doi: 10.1111/j.1365-2249.2009.03953.x. Erratum in: Clin Exp Immunol. 2009 Sep;157(3):446.

PMID:
19630865
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Capacity of the manufacturing process of Flebogamma(®) DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent.

Diez JM, Caballero S, Belda F, Otegui M, Gajardo R, Jorquera JI.

Biologicals. 2010 Nov;38(6):670-4. doi: 10.1016/j.biologicals.2010.08.003. Epub 2010 Sep 22.

PMID:
20863716
[PubMed - indexed for MEDLINE]
12.

Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.

Briseid K, Hoem NO, Johannesen S, Haug K.

Thromb Res. 1995 May 1;78(3):239-50.

PMID:
7631304
[PubMed - indexed for MEDLINE]
13.

Factor XII activation is essential to sustain the procoagulant effects of particulate matter.

Kilinç E, Van Oerle R, Borissoff JI, Oschatz C, Gerlofs-Nijland ME, Janssen NA, Cassee FR, Sandström T, Renné T, Ten Cate H, Spronk HM.

J Thromb Haemost. 2011 Jul;9(7):1359-67. doi: 10.1111/j.1538-7836.2011.04280.x.

PMID:
21481175
[PubMed - indexed for MEDLINE]
14.

Factor XI contributes to thrombin generation in the absence of factor XII.

Kravtsov DV, Matafonov A, Tucker EI, Sun MF, Walsh PN, Gruber A, Gailani D.

Blood. 2009 Jul 9;114(2):452-8. doi: 10.1182/blood-2009-02-203604. Epub 2009 Apr 7.

PMID:
19351955
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.

Minnema MC, Pajkrt D, Wuillemin WA, Roem D, Bleeker WK, Levi M, van Deventer SJ, Hack CE, ten Cate H.

Blood. 1998 Nov 1;92(9):3294-301.

PMID:
9787166
[PubMed - indexed for MEDLINE]
Free Article
16.

Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity.

Mina A, Favaloro EJ, Koutts J.

Blood Coagul Fibrinolysis. 2012 Apr;23(3):203-7. doi: 10.1097/MBC.0b013e32834fa7d6.

PMID:
22322136
[PubMed - indexed for MEDLINE]
17.
18.

Factor XII-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation.

Gailani D, Broze GJ Jr.

Blood. 1993 Aug 1;82(3):813-9.

PMID:
8338946
[PubMed - indexed for MEDLINE]
Free Article
19.

Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.

Rugeri L, Quélin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y.

Haemophilia. 2010 Sep 1;16(5):771-7. doi: 10.1111/j.1365-2516.2010.02246.x. Epub 2010 Apr 8.

PMID:
20398070
[PubMed - indexed for MEDLINE]
20.

Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiency.

Berger M, Pinciaro PJ, Althaus A, Ballow M, Chouksey A, Moy J, Ochs H, Stein M.

J Clin Immunol. 2010 Mar;30(2):321-9. doi: 10.1007/s10875-009-9348-y. Epub 2009 Dec 8.

PMID:
19997861
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk